Clinical Trials Logo

Frailty clinical trials

View clinical trials related to Frailty.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT06334380 Enrolling by invitation - Breast Cancer Clinical Trials

VR for Surgical Prehabilitation and Rehabilitation

VR-PREP
Start date: April 15, 2024
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to determine feasibility and acceptability of of VR-physical therapy modules for surgical patients undergoing breast or axilla surgery in order to prepare for and recover from surgery.

NCT ID: NCT06184919 Enrolling by invitation - Surgery Clinical Trials

Preparing Older Adults for Major Surgery With Preoperative Comprehensive Geriatric Assessments

Start date: June 14, 2023
Phase:
Study type: Observational

The researchers will conduct observations, interviews, and focus groups with clinicians, staff and patients of the Perioperative Optimization of Senior Health (POSH) clinic, which conducts preoperative comprehensive geriatric assessments (pCGA) at UW Health to understand clinic processes and potential areas for improvement. The goal is to (1) create a process map describing clinic workflow and (2) redesign the process with healthcare providers and patients/families.

NCT ID: NCT06182228 Enrolling by invitation - Frailty Clinical Trials

Effectıvenes Of Frail Scale And Daily Lıfe Activity Assesment For Major Abdominal Surgery Patients

Start date: June 1, 2022
Phase:
Study type: Observational [Patient Registry]

The effectiveness of assessing postoperative outcomes in eldely patients undergoing major abdominal surgery through the Frailty Scale and Katz Activities of Daily Living evaluation is investigated in individuals aged 65-85. The secondary objective is to determine the prevalence of frailty in patients undergoing surgical procedures.

NCT ID: NCT06135740 Enrolling by invitation - Cognitive Function Clinical Trials

Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults

INSPIOR
Start date: November 8, 2023
Phase: N/A
Study type: Interventional

The goal of this prospective, single site, interventional randomized control trial is to treat age related health conditions in adults older than 65 years and functional independence. The main question of the study is to answer the effectiveness of notification on activity, sleep, and nutrition based on wearable device Fitbit recorded data for the improvement of health conditions including intellectual property and physical function, compared to usual care. Participants in the intervention arm will be given a Fitbit Charge 5 device and asked to wear this for the duration of the study, including during sleep. The study intervention will run for 6 months. Notifications will be issued using a monitoring software in Japanese, and issued automatically to participants. Participants in the control arm will be given a routine care and health-related information. Researchers will compare cognitive performance, muscle mass and physical activity between the two groups to see if the notification based on Fitbit data would promote the health conditions of older adults.

NCT ID: NCT05993572 Enrolling by invitation - Depression Clinical Trials

HEalthy Aging Team Supported Home-care Services (HEAT-YASAM)

HEAT-YASAM
Start date: June 15, 2023
Phase:
Study type: Observational [Patient Registry]

Depending on the YASAM project which was established to home-visit evaluate community-dwelling older adults (80 years of age and over), we aimed to determine the prevalence (prevalence) of geriatric syndromes (dependence, frailty, malnutrition, depression, dementia, comorbidity burden, polypharmacy) in these individuals and to determine possible changes in the follow-up of the patients during the 2-year follow-up period. (HEAVEN trial)

NCT ID: NCT05863611 Enrolling by invitation - Clinical trials for Type 2 Diabetes Mellitus

The Impact of Frailty in Type 2 Diabetes

Start date: May 20, 2023
Phase:
Study type: Observational

The purpose of our work; To investigate the effect of frailty on balance and fall risk in individuals with type 2 diabetes.The reason why participants the investigators invited to the study is participants diagnosis of Type 2 Diabetes.During the research, a questionnaire form (age, gender, educational status, etc.) in which participants demographic information will be recorded for evaluation purposes and a consent form for participation in the study will be filled. Standardized Mini Mental Test will be applied. Then fragility will be evaluated with the Fried Fragility Index. Fall assessment will be assessed with the Fall Risk Self-Assessment Scale and balance assessment will be made with the Tinetti Balance. participants will not need to spend a long time for all assessments. The time required for the assessment will be around 30 minutes.

NCT ID: NCT05581082 Enrolling by invitation - Frailty Clinical Trials

Understanding Changes in Physical Function Using Principles of Precision Medicine

Start date: August 18, 2022
Phase:
Study type: Observational [Patient Registry]

This is a pilot, feasibility study and the purpose of this study is exploratory. The goal is to provide the PI and study team with data using metabolomics that can be used to: a) demonstrate an ability to use such data in a future grant application; b) obtain data that determines the relationship between changes in physical function (objective and subjective) and potential metabolites.

NCT ID: NCT05411393 Enrolling by invitation - Frailty Clinical Trials

Synergizing Home Health Rehabilitation Therapy

Start date: October 6, 2022
Phase: N/A
Study type: Interventional

The objective of this project is to pilot test an ADL (activities of daily living)-enhanced program as an adjuvant therapy to usual home health rehabilitation to improve patient outcomes. The project will compare the ADL-enhanced program plus usual care with usual care using an RCT design in home health patients.

NCT ID: NCT05307666 Enrolling by invitation - Aging Clinical Trials

MinMed: Do Older Adults do Better With Less Medication

Start date: July 28, 2022
Phase: Phase 4
Study type: Interventional

Many health care providers believe "less-is-more" for older adults, and evidence suggests minimizing certain medications might improve health outcomes. While this evidence focuses on specific medications believed potentially problematic for seniors, it is really adverse reactions to COMMON medications (e.g. medications lowering blood sugar or treating pain) that bring older adults to emergency departments. Knowing recommended drug doses are lower in seniors, and knowing most adverse drug reactions are dose-related, the investigators are organizing primary care providers (family physicians and nurse practitioners) to invite their patients 80 years and older on 6 or more medications to review with them whether some medications could be safely reduced. For drugs treating a symptom (e.g. heartburn), patients and providers will work together to find the lowest dose that provides the same benefit. For drugs that lower blood pressure or blood sugar, doses will be adjusted to keep blood pressure and blood sugar in the upper end of the target range, a range many providers feel to be safer for older adults. Each provider will invite half their eligible patients to a minimization visit at the start of the study, and invite the other half later - after the health effects of minimizing the early group's medications is assessed. To do this, investigators will compare early minimizers to those whose medicines have not yet changed using electronic health data routinely collected on all Albertans. We hypothesize that minimizing medications will prolong independence, reduce mortality and hospitalization, and improve quality of life. It is important to recognize that the intervention (reviewing all medications and determining the lowest effective doses) is already widely recommended as best practice when prescribing for older adults. Despite this however, such medication reviews only infrequently take place. In this study investigators hope to demonstrate that family physicians can minimize their own prescribing, and that organizing providers in a way that permits such reviews to take place can provide health benefits to patients.

NCT ID: NCT05054894 Enrolling by invitation - Age-Related Frailty Clinical Trials

Plasmapheresis for Treatment of Age-Related Frailty

Start date: March 19, 2021
Phase: Early Phase 1
Study type: Interventional

This study is designed to evaluate the efficacy of albumin-infused plasmapheresis, using the Fresenius Kabi 'Amicus' apheresis machine, among patients with age-related frailty characterized by reduced physical, cognitive and immunological functioning. Additionally, this study is designed to evaluate the safety and tolerability of repeated plasmapheresis treatment.